Seoul National University Hospital
Seoul, 03080, South Korea
NCT Number: NCT03291210
Hyperoxemia can produce various complications including oxidative stress and myocardial injury. We hypothesized that the normoxic group would have lower myocardial injury compared to hyperoxic group after transcatheter aortic valve replacement.
Looking for future studies?
Notify Me20 year–99 year
All sexes
Interventional
Not applicable
Seoul, 03080, South Korea
Hyperoxemia can produce various complications, such as excessive oxidative stress, hyperoxia-induced vasoconstriction, increased perfusion heterogeneity, and resultant myocardial injury. Previous studies have been observed higher mortality in patient group maintained with supranormal oxygenation after resuscitation from cardiac arrest. However, the effect of hyperoxia vs. normoxia on myocardial injury during transcatheter aortic valve replacement (TAVR) has not been well investigated. We hypothesized that the normoxic group would have lower myocardial injury compared to hyperoxic group after TAVR.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
receives inspired oxygen fraction of 0.3
receives inspired oxygen fraction of 0.8
Time frame: 72 hours after the end of procedure
Area under the curve of troponin I
Time frame: 72 hours after the end of procedure
Area under the curve of CK MB
Time frame: through procedure completion, an average of 3 hours
changes in cerebral oximetry during the procedure
Time frame: through admission completion, an average of 5 days
Newly onset delirium
Time frame: through admission completion, an average of 5 days
Newly onset acute kidney injury or renal replacement therapy
Time frame: through admission completion, an average of 5 days
Newly onset stroke, myocardial infarction or mortality
Seoul National University Hospital
Other
Effect of O2 Tension on Myocardial Injury During TAVI
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06468982
Acute Myocardial Infarction, Arterial Occlusive Diseases
Yakutiye, Erzurum, Turkey (Türkiye)
View Trial DetailsNCT03400553
Acute Myocardial Infarction, Troponin
Genk, Belgium
View Trial DetailsNCT02060760
Acute Coronary Syndrome, Behavior
Minneapolis, Minnesota, United States
View Trial DetailsNCT02285686
Cardiovascular Diseases, Critical Care
View Trial Details